Volume 35, 12 March 2004 | 3/2004 |
SPOT ON | |
Publication bias: studies with negative results often remain unpublished | |
NEW ON THE MARKET | |
Nadifloxacin (NADIXA) for acne Alopecia: what's the benefit of external minoxidil for women | |
THERAPIES FROM A CRITICAL VIEW POINT | |
Angiotensin converting enzyme inhibitors for patients with type 2 diabetes and albuminuria | |
a-t READERS' QUESTIONS AND COMMENTS | |
Metformin: to be discontinued before surgery? | |
IN BRIEF | |
Again: escitalopram is not better than citalopram | |
CURRENT ADR NETWORK REPORT | |
Hypersexuality under dopamine agonist Pramipexole | |
SIDE EFFECTS | |
Dementia: olanzapine (ZYPREXA) increases mortality | |
© arznei-telegramm 3/2004 | ||